Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Active, not recruiting · NCT05995405 · Registry updated 2024-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Active, not recruiting | Phase 3 | 2024-10-01 | NCT05995405 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grace Therapeutics Inc. | 1 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.